Cargando…

Potential Renal Damage Biomarkers in Alport Syndrome—A Review of the Literature

Alport syndrome (AS) is the second most common cause of inherited chronic kidney disease. This disorder is caused by genetic variants on COL4A3, COL4A4 and COL4A5 genes. These genes encode the proteins that constitute collagen type IV of the glomerular basement membrane (GBM). The heterodimer COL4A3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Ana Marta, Lopes, Daniela, Almeida, Clara, Santos, Sofia, Malheiro, Jorge, Lousa, Irina, Caldas Afonso, Alberto, Beirão, Idalina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266446/ https://www.ncbi.nlm.nih.gov/pubmed/35806283 http://dx.doi.org/10.3390/ijms23137276

Ejemplares similares

New Potential Biomarkers for Chronic Kidney Disease Management—A Review of the Literature
por: Lousa, Irina, et al.
Publicado: (2020)

O.4.4-3 Developing a bespoke undergraduate physical activity course for a Portuguese Medical School - the VANGUARD European Union Erasmus+ project
por: Mendes, Romeu, et al.
Publicado: (2023)

Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases
por: Beirão, João Melo, et al.
Publicado: (2015)

Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients
por: Lascasas, Josefina Maria Sousa Santos, et al.
Publicado: (2019)

Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
por: Malheiro, Jorge, et al.
Publicado: (2014)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

Biomarkers and Imaging Findings of Anderson–Fabry Disease—What We Know Now
por: Beirão, Idalina, et al.
Publicado: (2017)

Renal denervation in a patient with Alport syndrome and rejected renal allograft
por: Raju, Narayana, et al.
Publicado: (2015)

Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011)

Alport's Syndrome in Pregnancy
por: Mehta, Suchita, et al.
Publicado: (2013)

TNFR2 as a Potential Biomarker for Early Detection and Progression of CKD
por: Lousa, Irina, et al.
Publicado: (2023)

The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD
por: Lousa, Irina, et al.
Publicado: (2022)

Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
por: Trimarchi, H., et al.
Publicado: (2016)

Monoclonal gammopathy of renal significance: Diagnostic workup
por: Correia, Sofia O, et al.
Publicado: (2017)

Sindrome de Alport : revisión bibliográfica
por: Velasco Bello, Fernando Mario
Publicado: (1994)

Alport syndrome: facts and opinions
por: Kashtan, Clifford
Publicado: (2017)

Genetic diagnosis of Alport syndrome
por: Cheong, Hae Il
Publicado: (2019)

Alport Syndrome Classification and Management
por: Warady, Bradley A., et al.
Publicado: (2020)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

Auditory Perception in Alport’s Syndrome
por: Viveiros, Carla Mherlyn, et al.
Publicado: (2015)

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012)

Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease
por: Kelly, Yvelynne P., et al.
Publicado: (2016)

Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation
por: Kashtan, Clifford E
Publicado: (2018)

Renal impairment in Alport syndrome pregnant woman: Case report and review of the literature
por: Pepe, Franco, et al.
Publicado: (2020)

TNF-α induces Claudin-1 expression in renal tubules in Alport mice
por: Iida, Manami, et al.
Publicado: (2022)

Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age
por: Günthner, Roman, et al.
Publicado: (2022)

The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model
por: Sannomiya, Yuya, et al.
Publicado: (2021)

The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014)

Anterior lenticonus associated with Alport syndrome
por: Jinagal, Jitender, et al.
Publicado: (2018)

Pulmonary calcinosis associated with Alport syndrome
por: Mismetti, Valentine, et al.
Publicado: (2022)

Alport Syndrome: A Comprehensive Review
por: Adone, Avanti, et al.
Publicado: (2023)

Temporal Bone Histopathology of X‐linked Inherited Alport Syndrome
por: Ungar, Omer J., et al.
Publicado: (2018)

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
por: Ge, Mengyuan, et al.
Publicado: (2023)

ALPORT SYNDROME: SIGNIFICANCE OF GINGIVAL BIOPSY IN THE INITIAL DIAGNOSIS AND PERIODONTAL EVALUATION AFTER RENAL TRANSPLANTATION
por: Toygar, Hilal Uslu, et al.
Publicado: (2009)

Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective study
por: Katsuma, Ai, et al.
Publicado: (2018)

Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome
por: Yokota, Tsubasa, et al.
Publicado: (2017)

Molecular testing for adult type Alport syndrome
por: Pont-Kingdon, Genevieve, et al.
Publicado: (2009)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

It is an Alport syndrome, not a simple hypertensive retinopathy
por: Gadde, Aruna Kumari, et al.
Publicado: (2018)

Glomerular endothelial cell heterogeneity in Alport syndrome
por: Soloyan, Hasmik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1jkfjh800p0jjtvcu1t64tcnrv